Literature DB >> 10981056

Obesity, hypertension, and vascular disease.

K M Sowers1, J R Sowers.   

Abstract

Obesity, hypertension, and related metabolic and hemodynamic abnormalities contribute significantly to cardiovascular disease in westernized societies such as the United States. Both obesity and hypertension are more prevalent among minorities such as black and Hispanic populations. Obesity substantially increases the likelihood of hypertension, and weight reduction has been shown to be an effective hygienic measure in reducing blood pressure. There is accumulating evidence that central obesity, particularly obesity that is distributed in the paraomental (visceral) region, especially predisposes one to hypertension and related metabolic abnormalities that contribute cerebrovascular disease.

Entities:  

Mesh:

Year:  1999        PMID: 10981056     DOI: 10.1007/s11906-999-0009-6

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  58 in total

1.  Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men.

Authors:  A D Hargreaves; R L Logan; R A Elton; K D Buchanan; M F Oliver; R A Riemersma
Journal:  Atherosclerosis       Date:  1992-05       Impact factor: 5.162

2.  Absolute fat mass, percent body fat, and body-fat distribution: which is the real determinant of blood pressure and serum glucose?

Authors:  D Spiegelman; R G Israel; C Bouchard; W C Willett
Journal:  Am J Clin Nutr       Date:  1992-06       Impact factor: 7.045

3.  Abdominal fat distribution and metabolic risk factors: effects of race.

Authors:  J C Lovejoy; J A de la Bretonne; M Klemperer; R Tulley
Journal:  Metabolism       Date:  1996-09       Impact factor: 8.694

4.  Modest weight gain and the development of diabetes: another perspective.

Authors:  J R Sowers
Journal:  Ann Intern Med       Date:  1995-04-01       Impact factor: 25.391

5.  Insulin resistance versus insulin secretion in the hypertension of obesity.

Authors:  N W Istfan; C S Plaisted; B R Bistrian; G L Blackburn
Journal:  Hypertension       Date:  1992-04       Impact factor: 10.190

6.  Effects of weight reduction on cellular cation metabolism and vascular resistance.

Authors:  D B Jacobs; J R Sowers; A Hmeidan; T Niyogi; L Simpson; P R Standley
Journal:  Hypertension       Date:  1993-03       Impact factor: 10.190

7.  Body fat distribution in pre- and post-menopausal women: metabolic and anthropometric variables and their inter-relationships.

Authors:  M Zamboni; F Armellini; M P Milani; M De Marchi; T Todesco; R Robbi; I A Bergamo-Andreis; O Bosello
Journal:  Int J Obes Relat Metab Disord       Date:  1992-07

8.  Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk.

Authors:  S Agewall; B Fagerberg; S Attvall; I Wendelhag; V Urbanavicius; J Wikstrand
Journal:  Stroke       Date:  1995-06       Impact factor: 7.914

9.  Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up.

Authors:  A Fontbonne; M A Charles; N Thibult; J L Richard; J R Claude; J M Warnet; G E Rosselin; E Eschwège
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

10.  Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators.

Authors:  A R Folsom; J H Eckfeldt; S Weitzman; J Ma; L E Chambless; R W Barnes; K B Cram; R G Hutchinson
Journal:  Stroke       Date:  1994-01       Impact factor: 7.914

View more
  2 in total

1.  Relationship between obesity and pulse pressure in children: results of the National Health and Nutrition Survey (NHANES) 1988-1994.

Authors:  Gangadarshni Chandramohan; Kamyar Kalantar-Zadeh; Dulcie Kermah; Sheena Cecille Marie Go; Nosratola D Vaziri; Keith C Norris
Journal:  J Am Soc Hypertens       Date:  2012 Jul-Aug

Review 2.  Role of ACE inhibitors in treating hypertensive diabetic patients.

Authors:  Dmitri Kirpichnikov; James R Sowers
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.